Financial

Catalyst Pharmaceuticals, Inc. (CPRX) finishes with 1.02% while stock price is worth at $2.96

0

Catalyst Pharmaceuticals, Inc. (CPRX):

Catalyst Pharmaceuticals, Inc. (CPRX) closed its day with gain 1.02% and ended at the price of $2.96. CPRX stock is a part of Drugs – Generic industry and belongs to Healthcare sector. The stock traded volume of 1 million shares during its recent trading session while it’s an average volume stands around 0.65 million shares. The average numbers of shares are traded in a security per day, during the recent 3-month period. The stock has relative volume of 1.55. Relative volume is ratio between current volume and 3-month average value, intraday adjusted. The price to sales ratio is 17.

Analysts Opinion:

Analysts’ consensus recommendation is observed at 2.00. Rating Scale; where 1.0 rating means Strong Buy, 2.0 rating signify Buy, 3.0 recommendation reveals Hold, 4.0 rating score shows Sell and 5.0 displays Strong Sell signal.

Performance Check:

To evaluate the CPRX recent performance, look at its past history: the stock sticks almost -5.13% during last week. It showed the change of 17.46% in last one month. It remained at 6.86% over last 3 months. The stock performed 159.65% in last 12- months and its year to date performance is standing at 181.90%.

Technical Indicators:

Relative Strength Index (RSI) is 58.17 and ATR value of company is 0.17. The stock volatility for month is 6.08% and for week it is 7.10%.The stock traded 193.07% to its 52 week low and was changed -8.64% from its 52 week high as of last close. Beta factor, which measures the riskiness of the security, was observed as 1.52. CPRX’s value Change from Open was at 1.37% with a Gap of -0.34%.

USA based company Catalyst Pharmaceuticals, Inc. (CPRX)’s latest closing price was 32.43% from the average-price of 200 days while it maintained a distance from the 50 Day Moving Average at 11.07% and 4.48% compared with the 20 Day Moving Average.

EPS Growth about CPRX:

EPS growth in past 5 year was 5.80%

EPS growth in next year is estimated to reach -26.10% while EPS growth estimate for this year is set at 12.90%.

About the author / 

Leave a reply

Your email address will not be published. Required fields are marked *

About Us

WSnews4investors is the influential source for financial news and Opinion Company with content which delivered over the Internet. WSnews4investors is a dynamic and innovative financial media outlet that empowers investors with high-quality, unique content that is coveted by Wall Street’s traders.

Newsletter